Samer Al Hadidi, MD,MS,FACP

Myeloma is a curable malignancy #mmsm

Yes it is curable

The cure rate is not ideal (not all/most patients are cured)- there is still work to be done to improve

We estimate that one out of three patients with standard risk myeloma (vast majority of cases) are cured

🧵

Great discussion on the topic of “me too or not me too”: BCMA Saturation: Redundancy or Real Choice?

#mmsm #AAADV26 @utswcancer

#AAADV26 Peter Marks keynote Expediting the expedited: Advancing the Pace of Medical Product Development

Gene therapies in the US-2026

#voted in Texas for a better future

Final analysis of DREAMM-3 #mmsm @BloodCancerJnl

✅ As monotherapy, belantamab is not better than Pom/Dex (no difference in PFS, PFS2 and OS) even with longer follow up

✅ About 20% (24 of 122) of patients who had a first grade ≥2 eye exam finding still hadn’t recovered from it at their last visit

➡️ rdcu.be/rypZoXm45vba